* As of 31/12/16 ZLD had approximately $3.8m in the bank.
* The company's December 2016 Quarterly Report highlighted that the total estimated cash outflows for the next quarter would be $913k. Note, this includes $247k for the outstanding liabilities incurred by ZLD prior to the completion of the acquisition of Zelda Therapeutics on the 18th November 2016.
* ZLD have just raised $6m, bringing their total cash in bank now to $8.3m.
So since the end of December the company has spent approximately $1.5m.
$3.8m (end Dec 2016) + $6.0m (CR 30/03/17) = $9.8m.
$9.8m - $8.3m = $1.5m cash outflows.
As of the 30/03/17 the company now have $8.3m in the bank.
Let's assume that the company's future quarterly outflows bump up to around the $1.5m mark, at that quarterly spend they would have enough money for approximately 5.5 quarters in order to execute their current clinical / research programs and to also pursue any new opportunities to grow its clinical pipeline.
Tony
- Forums
- ASX - By Stock
- ZLD
- Ann: Zelda Successfully Completes Capital Raising
Ann: Zelda Successfully Completes Capital Raising, page-17
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
75.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.510M |
Open | High | Low | Value | Volume |
75.0¢ | 78.5¢ | 72.0¢ | $1.457K | 1.951K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3528 | 72.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
75.0¢ | 791 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3528 | 0.720 |
2 | 6327 | 0.710 |
1 | 3000 | 0.700 |
1 | 2000 | 0.690 |
3 | 2068 | 0.680 |
Price($) | Vol. | No. |
---|---|---|
0.750 | 791 | 1 |
0.940 | 40000 | 1 |
0.980 | 1021 | 2 |
1.010 | 1000 | 1 |
1.020 | 5000 | 1 |
Last trade - 15.59pm 27/09/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |